The AI for Good Lab is part of Microsoft’s philanthropic initiatives and partners with changemakers across the globe, providing computing power, AI experts and data scientists to help organizations’ subject matter experts in their work. This round of grantees includes the University of Washington’s Institute for Protein Design, Washington State University, Virufy, Providence, and the Institute for Health Metrics and Evaluation, among others.

These investments underscore Washington’s leadership in AI and life sciences and its commitment to fostering homegrown innovation.

The post Microsoft’s AI for Good Lab Invests in 20 State Change-Makers appeared first on Life Science Washington.

As part of the partnership, AGC Biologics will develop the cell line and create a master cell bank (MCB) for Novelty Nobility’s bispecific antibody candidate at its Copenhagen facility. Novelty Nobility will leverage AGC Biologics’ expertise, proprietary CHEF1 expression technology, and additional process development.

The post AGC Biologics & Novelty Nobility Partner for Cell Line Development appeared first on Life Science Washington.

The post Alpenglow Biosciences, an LSW Institute WIN Graduate, and ZEISS Launch Advanced Inverted Light-Sheet Microscopy Platform for Research and Clinical Use appeared first on Life Science Washington.

Founded in 2021, CueZen leverages AI and data from sensor-based devices to help people adhere to care plans and promote healthy habits.

Customers include healthcare organizations such as Titan and Microport. CueZen also sells to the Singapore government, which uses the software for its wellness programs.

CueZen CEO and co-founder Ankur Teredesai previously founded KenSci, a Seattle healthtech startup acquired by Tegria in 2021. He’s a longtime professor at the University of Washington.

The post Seattle Startup CueZen Raises $5M for Personalized Health Coaching Software appeared first on Life Science Washington.

The post LumiThera’s LIGHTSITE IIIB Extension Trial Topline Results Show Extended Vision Improvement in Dry AMD Subjects appeared first on Life Science Washington.

The post Fred Hutch Study Finds Genetic Driver of Drug Resistance in Small Cell Lung Cancer appeared first on Life Science Washington.

The post A New Approach to Autoimmune Disease Treatment Takes a Big Step Forward appeared first on Life Science Washington.

In the first 100 days of President Donald Trump’s administration, hundreds of active research grants have been canceled or threatened nationwide. Now, the administration might propose deep cuts to the Food and Drug Administration, National Institutes of Health and other federal health agencies. 

Buckner was speaking last month at Life Science Innovation Northwest, Seattle’s marquee gathering of the biotech industry. Most years, the two-day conference sees scientists, investors and others involved in the region’s $41 billion biotech industry dish about the latest discoveries and collaborations for treating diseases and improving health, while making deals, scoring jobs or just getting some good advice.

The post As Trump Attacks Science, WA’s $41B Biotech Sector Caught in Crossfire appeared first on Life Science Washington.

Gestalt’s technology aims to improve cancer detection, allowing for real-time collaboration between health providers and pathologists and faster diagnosis.

The new funding will support efforts to reach more customers, improve the tool’s AI capabilities, and aid in the pursuit of Food and Drug Administration clearance. The digital analysis technology is increasingly important, the startup notes, given the rising cancer rates and declining number of pathologists.

“We’ve already streamlined how pathologists navigate fragmented systems by creating PathFlow, a unified platform for viewing pathology cases digitally and collaborating with leading experts in real-time without the need to ship specimens,” Gestalt CEO Dan Roark said in a statement. “Now, we’ll accelerate innovation and scale our reach to meet the growing demands of modern pathology.”

The post Spokane Startup Gestalt Diagnostics Raises $7.5M to Advance AI-Enabled Cancer Detection appeared first on Life Science Washington.

The post Curi Bio and Cook MyoSite Announce Strategic Partnership appeared first on Life Science Washington.